Literature DB >> 962222

Erythrocyte filterability and heme catabolism during the menstrual cycle.

C Mercke, B Lundh.   

Abstract

Erythrocyte filterability, reticulocyte count, total serum bilirubin, and CO hemoglobin percent saturation (COHb) were measured throughout one menstrual cycle in 17 women. The filterability was significantly depressed during the progesterone phase compared with the estrogen phase. The depressed filterability was accompanied by significant increases in reticulocyte count, total serum bilirubin, and COHb. Significant correlations were seen between filterability, reticulocyte count, and total serum bilirubin. However, COHb did not correlate significantly with any of the other variables studied. This is probably due to increased ventilation during the progesterone phase balancing the increased endogenous production of CO. It is possible that cyclic variations in heme turnover are related to changes in erythrocyte characteristics during the progesterone phase.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 962222     DOI: 10.7326/0003-4819-85-3-322

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  4 in total

1.  Effect of total leucocyte count on whole blood filterability in patients with peripheral vascular disease.

Authors:  M J Alderman; A Ridge; A A Morley; R G Ryall; J A Walsh
Journal:  J Clin Pathol       Date:  1981-02       Impact factor: 3.411

2.  Altered haemorheology in oral-contraceptive users.

Authors:  P C Buchan; H N Macdonald
Journal:  Br Med J       Date:  1980-04-05

3.  Removal of the influence of plasma volume fluctuations for the athlete biological passport and stability of haematological variables in active women taking oral contraception.

Authors:  Basile Moreillon; Tristan Equey; Tiffany Astolfi; Olivier Salamin; Raphael Faiss
Journal:  Drug Test Anal       Date:  2022-01-17       Impact factor: 3.234

4.  Anaemia in patients with solid tumours and the role of erythrocyte deformability.

Authors:  C E Mercke
Journal:  Br J Cancer       Date:  1981-09       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.